tradingkey.logo
tradingkey.logo
Search

Addex Therapeutics Ltd

ADXN
Add to Watchlist
5.590USD
-0.005-0.09%
Close 07-31 16:00ETQuotes delayed by 15 min
5.56MMarket Cap
LossP/E TTM

ADXN Financials

See Addex Therapeutics Ltd's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

Addex Therapeutics Ltd Earnings Date

Latest Release
Jun 25, 2026
EPS / Forecast
-2.21/--
Revenue / Forecast
--/--
Period
FY2025 Earnings
Revenue(YoY)
38.33K
-91.77%
EPS(YoY)
-9.05
-192.34%
Analyst Rating
2025/08/20
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022H2
FY2022Q1
FY2022H1
FY2021Q4
FY2021Q3
Financial Indicators
EPS
---2.21
-39.66%-2.34
2.67%-2.10
-115.30%-2.66
62.58%-1.68
53.08%-2.16
451.57%17.39
14.71%-4.35
43.82%-4.48
56.94%-4.60
79.39%-4.95
---5.10
---7.97
---10.68
---23.99
----
----
----
----
----
Revenue
----
-99.93%310.48
-7.97%62.01K
-65.48%44.01K
161.22%453.71K
-81.91%67.39K
-81.86%127.48K
-50.45%268.88K
-72.05%173.68K
-13.46%372.49K
263.38%702.83K
105.34%542.63K
42.75%621.44K
-47.86%430.42K
-83.55%193.42K
-16.54%1.05M
-74.09%264.26K
-79.24%456.03K
-79.20%435.32K
639.91%825.51K
Net Profit
---2.18M
-67.39%-2.30M
-11.60%-1.97M
-115.64%-2.23M
57.37%-1.37M
40.33%-1.77M
578.73%14.24M
-35.81%-3.53M
14.94%-3.22M
30.38%-2.96M
60.29%-2.98M
58.76%-2.60M
18.21%-3.79M
-8.50%-4.25M
-45.62%-7.49M
5.98%-8.04M
-116.18%-6.31M
-71.18%-13.82M
-97.04%-4.63M
-8.86%-3.92M
Net Margin
----
-247313.38%-739347.58%
-21.46%-3179.90%
-326.15%-5385.33%
48.77%-298.83%
-1112.71%-2618.08%
-1431.72%-1263.70%
-324.64%-312.96%
4.33%-583.33%
78.15%-215.89%
97.87%-82.50%
---73.70%
---609.75%
---988.13%
---3873.17%
----
----
----
----
----
Gross Margin
----
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
--100.00%
--100.00%
--100.00%
--100.00%
----
----
----
----
----
Debt to assets ratio
--2.15%
38.60%0.55%
38.61%0.50%
92.08%0.45%
-94.70%0.39%
-93.17%0.36%
-90.91%0.23%
-70.31%1.05%
64.65%7.42%
44.22%5.27%
-12.71%2.58%
--3.55%
--4.51%
--3.65%
--2.96%
----
----
----
----
----
Revenue
----
-99.93%310.48
-7.97%62.01K
-65.48%44.01K
161.22%453.71K
-81.91%67.39K
-81.86%127.48K
-50.45%268.88K
-72.05%173.68K
-13.46%372.49K
263.38%702.83K
105.34%542.63K
42.75%621.44K
-47.86%430.42K
-83.55%193.42K
-16.54%1.05M
-74.09%264.26K
-79.24%456.03K
-79.20%435.32K
639.91%825.51K
Operating profit
---612.30K
-92.12%-975.58K
-21.13%-870.43K
10.84%-886.77K
38.34%-507.79K
15.23%-718.59K
-125.73%-994.55K
-127.00%-902.06K
77.32%-823.48K
79.87%-847.72K
91.82%-440.60K
93.03%-397.38K
21.74%-3.63M
-62.70%-4.21M
-29.01%-5.39M
6.92%-7.95M
-140.05%-5.70M
-68.87%-11.08M
-122.56%-4.64M
23.50%-2.59M
Net Profit
---2.18M
-67.39%-2.30M
-11.60%-1.97M
-115.64%-2.23M
57.37%-1.37M
40.33%-1.77M
578.73%14.24M
-35.81%-3.53M
14.94%-3.22M
30.38%-2.96M
60.29%-2.98M
58.76%-2.60M
18.21%-3.79M
-8.50%-4.25M
-45.62%-7.49M
5.98%-8.04M
-116.18%-6.31M
-71.18%-13.82M
-97.04%-4.63M
-8.86%-3.92M
Current assets
--1.49M
-45.68%2.12M
-38.32%2.97M
-35.78%3.35M
-22.43%3.90M
-23.27%4.82M
-46.24%5.22M
-51.63%3.66M
-40.58%5.03M
-47.06%6.28M
-15.31%9.71M
-59.37%7.56M
-64.79%8.47M
-36.65%11.86M
-49.51%11.46M
-64.79%8.47M
-33.19%18.60M
-49.51%11.46M
9.24%24.05M
-10.47%18.72M
Total current liabilities
--1.53M
71.16%1.51M
40.59%1.48M
38.26%1.45M
-74.29%884.14K
-50.26%1.05M
-65.38%1.05M
48.19%5.16M
-3.16%3.44M
-49.55%2.11M
-32.63%3.03M
-19.09%3.48M
-21.67%3.55M
19.14%4.18M
12.95%4.50M
-21.67%3.55M
-11.91%4.31M
12.95%4.50M
10.81%4.53M
45.85%3.51M
Total assets
--5.96M
-31.76%8.03M
-36.02%9.21M
-29.62%10.73M
113.38%11.77M
114.51%14.39M
51.64%15.24M
-53.60%3.70M
-38.43%5.52M
-45.92%6.71M
-15.68%10.05M
-58.39%7.97M
-63.74%8.96M
-36.02%12.41M
-48.80%11.92M
-63.74%8.96M
-32.73%19.16M
-48.80%11.92M
8.38%24.71M
-9.14%19.39M
Total liabilities
--1.84M
82.74%2.02M
31.77%1.72M
40.14%1.63M
-73.44%1.10M
-45.44%1.31M
-63.73%1.16M
48.23%5.22M
14.00%4.15M
-44.85%2.40M
-32.22%3.21M
-31.21%3.52M
-40.74%3.64M
-14.19%4.35M
-14.31%4.73M
-40.74%3.64M
-21.75%5.12M
-14.31%4.73M
-2.30%6.15M
19.53%5.07M
Total equity
--4.11M
-43.60%6.02M
-42.79%7.48M
-35.39%9.10M
683.65%10.67M
203.47%13.08M
105.73%14.08M
-134.22%-1.52M
-74.39%1.36M
-46.50%4.31M
-4.79%6.84M
-68.31%4.45M
-71.37%5.31M
-43.74%8.06M
-59.53%7.19M
-71.37%5.31M
-36.00%14.04M
-59.53%7.19M
12.45%18.56M
-16.25%14.32M
Net operating income
---978.09K
-2618.22%-776.12K
-44.78%-667.25K
83.30%-508.99K
95.91%-28.55K
81.83%-460.87K
0.14%-3.05M
0.95%-2.51M
77.99%-697.52K
9.04%-2.54M
49.63%-3.05M
51.93%-2.53M
1.10%-3.17M
-0.48%-2.79M
14.64%-6.06M
0.39%-5.96M
-71.04%-5.27M
-11.22%-11.35M
-516.19%-3.20M
0.60%-2.78M
Net investment
----
100.00%0.00
1213.62%75.11K
-117.29%-892.16K
-1233.12%-18.12K
-779.23%-6.74K
186481.54%5.16M
100.00%0.00
-14457.00%-1.36K
-124.85%-767.12
---2.77K
---2.67K
99.96%-9.34
643.83%3.09K
100.00%0.00
111.37%3.08K
100.00%0.00
100.00%0.00
50.25%-26.47K
24.86%-567.57
Net financing
--84.30K
37662.39%95.45K
1565447.55%451.96K
1324.98%786.49K
99.64%-254.11
99.99%-28.87
-101.29%-64.20K
-82.94%186.89K
63.19%-71.22K
-105.19%-225.29K
3130.92%4.97M
240.09%1.10M
-102.18%-193.51K
4989.71%4.34M
65.60%-164.04K
-52.80%4.15M
-108.03%-782.15K
-110.11%-932.60K
1505.47%8.86M
2.17%-88.70K

FAQs

What is the total revenue of Addex Therapeutics Ltd?

According to Addex Therapeutics Ltd's FY2025 earnings report, its total revenue reached 38.33K, with a year-on-year change of 465.76K.

What are the current assets of Addex Therapeutics Ltd?

According to Addex Therapeutics Ltd's FY2025 earnings report, its current assets were 2.12M, with a year-on-year change of -45.68.

What are the total assets of Addex Therapeutics Ltd?

According to Addex Therapeutics Ltd's FY2025 earnings report, its total assets of Addex Therapeutics Ltd were 8.03M, with a year-on-year change of -31.76.

What are the total liabilities of Addex Therapeutics Ltd?

According to Addex Therapeutics Ltd's FY2025 earnings report, its total liabilities of Addex Therapeutics Ltd were 2.02M, with a year-on-year change of 82.74.

What is the total equity of Addex Therapeutics Ltd?

According to Addex Therapeutics Ltd's FY2025 earnings report, its total equity of Addex Therapeutics Ltd was 6.02M, with a year-on-year change of -43.60.

What is the net operating income of Addex Therapeutics Ltd?

According to Addex Therapeutics Ltd's FY2025 earnings report, its net operating income of Addex Therapeutics Ltd was -3.39M, with a year-on-year change of -8.25.

What is the net investment of Addex Therapeutics Ltd?

According to Addex Therapeutics Ltd's FY2025 earnings report, its net investment of Addex Therapeutics Ltd was -956.98K, with a year-on-year change of -118.14.

What is the net financing of Addex Therapeutics Ltd?

According to Addex Therapeutics Ltd's FY2025 earnings report, its net financing of Addex Therapeutics Ltd was 1.43M, with a year-on-year change of 1097.57.

What is the Earnings Per Share (EPS) of Addex Therapeutics Ltd?

According to Addex Therapeutics Ltd's FY2025 earnings report, its Earnings Per Share (EPS) was -9.05, with a year-on-year change of -192.34.

What is the net income of Addex Therapeutics Ltd?

According to Addex Therapeutics Ltd's FY2025 earnings report, its net income was -8.10M, with a year-on-year change of -201.05.

What is the net margin of Addex Therapeutics Ltd?

According to Addex Therapeutics Ltd's FY2025 earnings report, its net profit margin was -21489.19, with a year-on-year change of -1694.84.

What is the debt-to-asset ratio of Addex Therapeutics Ltd?

According to Addex Therapeutics Ltd's FY2025 earnings report, its debt-to-asset ratio was 0.55, with a year-on-year change of 38.60.

What is the Return on Equity (ROE) of Addex Therapeutics Ltd?

According to Addex Therapeutics Ltd's FY2025 earnings report, its Return on Equity (ROE) was -98.74, with a year-on-year change of -6.49.

What is the Return on Assets (ROA) of Addex Therapeutics Ltd?

According to Addex Therapeutics Ltd's FY2025 earnings report, its Return on Assets (ROA) was -83.18, with a year-on-year change of -28.93.

What is the operating profit of Addex Therapeutics Ltd?

According to Addex Therapeutics Ltd's FY2025 earnings report, its operating profit was -3.39M, with a year-on-year change of -8.25.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.